Topical Proparacaine Eye Drops to Improve the Experience of Patients Undergoing Intravitreal Injections

• Status: Completed
• Trial end date: 2018-02-01
• Target enrollment: 0
• Participant gender: All

Summary

The specific aims of this study are to compare patient experience with and without a proparacaine drop after povidone iodine.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Mayo Clinic
• Collaborators: Research to Prevent Blindness; VitreoRetinal Surgery, PA
• Treatments: Ophthalmic Solutions; Propoxycaine; Proxymetacaine

Criteria

Inclusion Criteria:

• patients undergoing intravitreal injection who do not have active eye infections

• greater than 18 years of age

Exclusion Criteria:

• patients younger than 18 years of age

• patients with active eye infections